Iridex Corp (IRIX)

Name: Iridex Corp (IRIX) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Build a valuation ↗↓ Download CSV

SEC name IRIDEX CORP · CIK 0001006045 · Nasdaq · Electromedical & Electrotherapeutic Apparatus

Sector Manufacturing
Incorporated DE
Fiscal year ends around Jan 3

For the year ended 2026-01-03 (fiscal 2025), Iridex Corp reported revenue of $52.67M. Revenue grew 8.2% from the prior annual period. Over the twelve months to 2026-07-04, revenue was $51.57M.

Key ratios (year ended 2026-01-03, fiscal 2025)

36.5%

Gross margin

-4.9%

Operating margin

-8.4%

Net margin

-90.1%

Return on year-end equity

8.2%

Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-13

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-07-04 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period ended	TTM to 2026-07-04	2026-01-03, Fiscal 2025	2024-12-28	2023-12-30	2022-12-31	2022-01-01, Fiscal 2021	2021-01-02, Fiscal 2020	2019-12-28	2018-12-29	2017-12-30	2016-12-31
Revenue	$51.57M	$52.67M	$48.67M	$51.87M	$56.97M	$53.90M	$36.35M	$43.45M	$42.60M	$41.59M	$46.16M
Cost of Revenue	$33.05M	$33.45M	$29.17M	$30.06M	$31.60M	$31.07M	$20.79M	$25.51M	$25.13M	$26.09M	$25.32M
Gross Profit	$18.53M	$19.23M	$19.50M	$21.81M	$25.37M	$22.83M	$15.56M	$17.94M	$17.47M	$15.50M	$20.84M
R&D Expense	$3.76M	$3.67M	$5.45M	$6.83M	$7.17M	$6.87M	$3.28M	$3.68M	$4.01M	$5.21M	$5.37M
Operating Income	-$2.78M	-$2.57M	-$8.30M	-$10.01M	-$7.54M	-$7.53M	-$6.58M	-$8.97M	-$12.87M	-$12.89M	-$2.56M
Depreciation & Amortization	$447.0K	$523.0K	$584.0K	$1.10M	$485.0K	$803.0K	$504.0K	$688.0K	$809.0K	$858.0K	$648.0K
EBITDA	-$2.33M	-$2.05M	-$7.72M	-$8.91M	-$7.06M	-$6.73M	-$6.08M	-$8.29M	-$12.06M	-$12.03M	-$1.92M
Net Income	-$3.55M	-$4.44M	-$8.91M	-$9.57M	-$7.55M	-$5.22M	-$6.33M	-$8.81M	-$12.81M	-$12.87M	-$11.71M
EPS (Diluted)	n/a	-$0.26	-$0.54	-$0.59	-$0.47	-$0.34	-$0.46	-$0.64	-$1.05	-$1.11	-$1.15
Total Assets	$27.26M	$29.15M	$29.14M	$34.44M	$42.29M	$48.69M	$27.97M	$34.81M	$41.67M	$41.65M	$48.14M
Total Liabilities	$23.62M	$24.23M	$27.04M	$24.91M	$25.06M	$25.39M	$10.60M	$12.11M	$11.71M	$11.12M	$8.98M
Long-Term Debt	n/a	n/a	$1.00M	n/a	n/a	n/a	$1.25M	n/a	n/a	n/a	n/a
Shareholders' Equity	$3.64M	$4.92M	$2.10M	$9.52M	$17.23M	$23.30M	$17.37M	$22.70M	$29.96M	$30.52M	$39.16M
Cash & Equivalents	$4.68M	$6.03M	$2.39M	$7.03M	$13.92M	$23.85M	$11.63M	$12.65M	$21.19M	$21.71M	$23.75M
Operating Cash Flow	-$1.73M	-$2.12M	-$7.29M	-$6.75M	-$9.52M	$8.22M	-$3.24M	-$7.91M	-$10.03M	-$3.56M	-$144.0K
Capital Expenditures	$270.0K	$143.0K	$13.0K	$109.0K	$286.0K	$213.0K	$97.0K	$128.0K	$440.0K	$575.0K	$1.06M
Free Cash Flow	-$2.00M	-$2.26M	-$7.30M	-$6.85M	-$9.80M	$8.00M	-$3.33M	-$8.04M	-$10.46M	-$4.14M	-$1.21M
Share Repurchases	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	$59.0K
Shares Outstanding	17.45M	17.31M	16.64M	16.25M	15.99M	15.88M	13.90M	13.79M	13.60M	11.60M	11.30M
Weighted Average Diluted Shares	n/a	16.93M	16.44M	16.13M	15.94M	15.42M	13.84M	13.71M	12.20M	11.55M	10.17M
EPS (Basic)	n/a	-$0.26	-$0.54	-$0.59	-$0.47	-$0.34	-$0.46	-$0.64	-$1.05	-$1.11	-$1.15

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView